Peregrine Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Peregrine Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-228,275	Closed	-$10.1M	–	345
2021 Q1	$10.1M	Sell	228,275 -8,055	-3%	-$338K	0.19%	231
2020 Q4	$8.24M	Buy	236,330 +99,597	+73%	+$3.54M	0.16%	241
2020 Q3	$4.98M	Sell	136,733 -14,780	-10%	-$550K	0.13%	233
2020 Q2	$5.69M	Buy	151,513 +2,168	+1%	+$86.7K	0.16%	177
2020 Q1	$5.48M	Sell	149,345 -34,813	-19%	-$1.35M	0.2%	149
2019 Q4	$7.46M	Buy	+184,158	New	+$6.87M	0.19%	189

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Peregrine Capital Management's PBH Position: Q2 2021 in Review

Peregrine Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2021, closing a stake of 228,275 shares — an estimated $10.1M sold.

Peregrine Capital Management first reported a position in PBH in Q4 2019 and held it in 6 quarters. The position peaked at $10.1M in Q1 2021. 228 funds tracked by Wall St. Rank hold PBH as of Q2 2021.

Peregrine Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2021 after selling out during the quarter.
Peregrine Capital Management sold 228,275 Prestige Consumer Healthcare shares in Q2 2021, an estimated $10.1M.
Peregrine Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2019 and held it in 6 quarters.
Peregrine Capital Management's Prestige Consumer Healthcare position peaked at $10.1M in Q1 2021.
228 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2021.

Based on Peregrine Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.